Fisher Asset Management LLC Sells 54,715 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Fisher Asset Management LLC reduced its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 14.9% in the fourth quarter, Holdings Channel reports. The fund owned 312,703 shares of the company’s stock after selling 54,715 shares during the quarter. Fisher Asset Management LLC’s holdings in Prestige Consumer Healthcare were worth $19,144,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently modified their holdings of the stock. Trexquant Investment LP grew its stake in Prestige Consumer Healthcare by 109.1% during the third quarter. Trexquant Investment LP now owns 8,340 shares of the company’s stock valued at $477,000 after acquiring an additional 4,351 shares in the last quarter. Qube Research & Technologies Ltd boosted its stake in Prestige Consumer Healthcare by 91.4% during the third quarter. Qube Research & Technologies Ltd now owns 72,092 shares of the company’s stock valued at $4,123,000 after buying an additional 34,430 shares during the period. Connors Investor Services Inc. purchased a new position in Prestige Consumer Healthcare during the third quarter worth about $1,569,000. Hsbc Holdings PLC increased its stake in Prestige Consumer Healthcare by 17.1% in the 3rd quarter. Hsbc Holdings PLC now owns 22,075 shares of the company’s stock worth $1,263,000 after acquiring an additional 3,226 shares during the last quarter. Finally, TD Asset Management Inc raised its holdings in shares of Prestige Consumer Healthcare by 11.1% in the 3rd quarter. TD Asset Management Inc now owns 46,100 shares of the company’s stock valued at $2,636,000 after acquiring an additional 4,600 shares in the last quarter. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Insider Activity at Prestige Consumer Healthcare

In other news, SVP Mary Beth Fritz sold 5,336 shares of Prestige Consumer Healthcare stock in a transaction that occurred on Thursday, February 8th. The stock was sold at an average price of $69.00, for a total value of $368,184.00. Following the sale, the senior vice president now directly owns 15,934 shares in the company, valued at approximately $1,099,446. The sale was disclosed in a filing with the SEC, which is available through this link. 1.60% of the stock is owned by company insiders.

Prestige Consumer Healthcare Stock Performance

NYSE:PBH opened at $70.00 on Monday. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.09 and a quick ratio of 1.92. Prestige Consumer Healthcare Inc. has a fifty-two week low of $55.96 and a fifty-two week high of $75.31. The business has a 50 day moving average price of $71.12 and a 200-day moving average price of $64.66.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings results on Thursday, February 8th. The company reported $1.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.04 by $0.02. Prestige Consumer Healthcare had a negative net margin of 7.11% and a positive return on equity of 14.09%. The business had revenue of $282.74 million for the quarter, compared to analyst estimates of $280.25 million. During the same quarter last year, the firm earned $1.04 EPS. The company’s revenue was up 2.6% on a year-over-year basis. Equities analysts forecast that Prestige Consumer Healthcare Inc. will post 4.33 earnings per share for the current year.

Analyst Ratings Changes

PBH has been the topic of several research analyst reports. TheStreet upgraded shares of Prestige Consumer Healthcare from a “c+” rating to a “b-” rating in a research report on Monday, February 12th. StockNews.com raised shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a report on Saturday, February 10th. One equities research analyst has rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $110.00.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.